Latest Breaking News On - Head of corporate communications investor relations - Page 3 : comparemela.com

Basilea Pharmaceutica AG: Basilea shareholders approve all proposals of the board of directors at the annual general meeting

Basilea Pharmaceutica AG: Basilea shareholders approve all proposals of the board of directors at the annual general meeting
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Basel stadtSwitzerland generalDennis riedlMartin nicklassonThomas wernerNicole onettoLeonard kruimerNils schrCaroline cronDomenico scalaPricewaterhousecoopers ltdBasilea pharmaceutica international ltdHead of corporate communications investor relationsBasilea pharmaceutica ltdSwiss exchangePharmaceutica ltd

Basilea shareholders approve all proposals of the board of directors at the annual general meeting

24.04.2024 - Allschwil, Switzerland, April 24, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported that shareholders .

Switzerland generalBasel stadtMartin nicklassonCaroline cronNicole onettoThomas wernerDomenico scalaLeonard kruimerNils schrHead of corporate communications investor relationsPricewaterhousecoopers ltdSwiss exchangeBasilea pharmaceutica international ltdBasilea pharmaceutica ltdCarole sableCorporate communications

EQS-Adhoc: Deutsche Beteiligungs AG: in-tech investment sold – unexpected contribution of 13 million euros to DBAG s second quarter 2023/2024 net income - adhoc - Börsennachrichten

EQS-Adhoc: Deutsche Beteiligungs AG: in-tech investment sold – unexpected contribution of 13 million euros to DBAG s second quarter 2023/2024 net income - adhoc - Börsennachrichten
stock-world.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stock-world.de Daily Mail and Mail on Sunday newspapers.

Roland rapeliusHead of corporate communications investor relationsDeutsche beteiligungsGerman securitiesAnnual reportCorporate communications

Deutsche Beteiligungs AG: in-tech investment sold – unexpected contribution of 13 million euros to DBAG s second quarter 2023/2024 net income

Deutsche Beteiligungs AG: in-tech investment sold – unexpected contribution of 13 million euros to DBAG s second quarter 2023/2024 net income
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Roland rapeliusHead of corporate communications investor relationsDeutsche beteiligungsGerman securitiesAnnual reportCorporate communications

Basilea awarded CARB-X grant to develop recently acquired novel class of antibiotics

Allschwil, Switzerland, April 09, 2024 Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal.

Switzerland generalBasel stadtNils schrLaurenz kellenbergerHead of corporate communications investor relationsBiomedical advanced researchAdministration for strategic preparednessHuman servicesBasilea pharmaceutica ltdBasilea pharmaceutica international ltdDevelopment authorityGermany federal ministry of educationSwiss exchangeBoston universityUs department of healthWorld health organization